BioNexus Gene Lab (BGLC) Fails to deliver data

Key failure to deliver metrics for BioNexus Gene Lab:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$0.06 M
• Last year FTD volume: A$0.06 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioNexus Gene Lab (BGLC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioNexus Gene Lab (BGLC) - since 2023

BioNexus Gene Lab (BGLC) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
ORIC Pharmaceuticals ORIC	A$1.5 M	A$5.99 M	🇺🇸 USA